John H. Stewart named center director of LSU Health New Orleans/LCMC Health Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

John H. Stewart was named center director of the LSU Health New Orleans/LCMC Health Cancer Center. 

He will also join the LSU Health New Orleans School of Medicine faculty as a professor of surgery.

Stewart will set the overall mission, vision and direction for multidisciplinary cancer care and cancer clinical research programs for LSU Health New Orleans and LCMC Health in his new leadership role. 

He and his team will develop a robust cancer clinical trials program, leverage resources to build an innovative targeted cancer research enterprise and create a comprehensive community outreach and engagement program to reduce cancer risk behaviors and cancer incidence. 

Initiatives will integrate disease-specific research and care delivery into a comprehensive patient-oriented approach to benefit patients of Louisiana and surrounding regions, including those currently underserved in accessing leading-edge cancer care.

Stewart, originally from Shreveport, was recruited from the University of Illinois College of Medicine in Chicago. There, he was a University of Illinois Presidential Scholar, professor of surgery in the College of Medicine, deputy director of the University of Illinois Cancer Center, and physician executive for oncology sciences at the University of Illinois Health.

Stewart’s role will be effective July 1.

Table of Contents

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login